Gruenenthal, Forest to jointly develop, commercialise analgesic compound
Both compounds were discovered and developed by Gruenenthal and represent novel molecules with pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. GRT 6005
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.